Nobivac^® Myxo-RHD Questions and Answers

For active immunisation of rabbits from 5 weeks of age onwards to reduce mortality and clinical signs of myxomatosis and to prevent mortality due to rabbit haemorrhagic disease (RHD) caused by classical RHD virus strains.

The onset of immunity for Nobivac Myxo-RHD is established 3 weeks after vaccination.

The duration of immunity for Nobivac Myxo-RHD is 1 year.

Pregnancy: Studies involving the use of the vaccine during early pregnancy were inconclusive, therefore vaccination is not recommended during the first 14 days of pregnancy.

Fertility: No safety study on the reproductive performance has been conducted in male rabbits (bucks). Therefore, the vaccination of breeding bucks is not recommended.

We do not hold specific data regarding use during lactation and therefore cannot recommend this use during this period.

Nobivac Myxo-RHD requires storage in a refrigerator between 2°C and 8°C. Do not freeze. Protect from light

There are no breed specific contraindications for Nobivac Myxo-RHD.

No information is available on the safety and efficacy of this vaccine when used with any other veterinary medicinal product. A decision to use this vaccine before or after any other veterinary medicinal product therefore needs to be made on a case by case basis.

After reconstitution, administer 1 dose of vaccine by subcutaneous injection to rabbits from 5 weeks of age onwards.

Nobivac Myxo-RHD should be administered annually.

No, there is no evidence to support cross-protection against variant strains of RHD (RHDV2 strains).